Clinical evaluation on fengweicao granule in treating benign prostatic hyperplasia / 中国中西医结合杂志
Chinese Journal of Integrated Traditional and Western Medicine
;
(12): 456-458, 2008.
Article
Dans Chinois
| WPRIM
| ID: wpr-343949
ABSTRACT
<p><b>OBJECTIVE</b>To report the effect of Fengweicao Granule (FWCCG), a Chinese herbal preparation made of herba Pteris multifidae, in treating benign prostatic hyperplasia (BPH).</p><p><b>METHODS</b>One hundred and fifty-five patients were assigned to two groups, the 108 patients in the treated group were administered orally with FWCG twice a day, 5 g every time; the 47 patients in the control group were treated with Proscar 5 mg per day for 3 months. The effects were evaluated by the change of the related indexes before and after treatment, including scoring by international prostatic symptom scale (I-PSS), maximum flowing rate of urine (MFR), residue urine volume (RU) in urinary bladder determined by abdominal B-ultrasonography and volume of prostate.</p><p><b>RESULTS</b>After being treated for 3 months, the I-PSS, MFR and RU improved remarkably in both groups (P <0.05 or P <0.01), but with no significant change in the volume of prostate, neither with significant difference in comparison between the two groups (P >0.05).</p><p><b>CONCLUSION</b>FWCG has a good effect with less adverse reaction in treating BPH.</p>
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Hyperplasie de la prostate
/
Médicaments issus de plantes chinoises
/
Finastéride
/
Pteris
/
Utilisations thérapeutiques
/
Diurèse
/
Traitement médicamenteux
/
Antienzymes
/
Médecine traditionnelle chinoise
Type d'étude:
Etude diagnostique
Limites du sujet:
Humains
/
Mâle
langue:
Chinois
Texte intégral:
Chinese Journal of Integrated Traditional and Western Medicine
Année:
2008
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS